ClinConnect ClinConnect Logo
Search / Trial NCT06644261

Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia

Launched by UNIVERSITY OF LOUISVILLE · Oct 14, 2024

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of providing pain relief for women suffering from pudendal neuralgia, a condition that causes chronic pain in the pelvic area. Specifically, the trial is comparing a technique called transvaginal finger-guided pudendal nerve block with another method known as fluoroscopy-guided trans gluteal pudendal nerve block. Both approaches aim to help relieve pain caused by issues with the pudendal nerve, but this study will determine if one method is more effective than the other.

To participate in this trial, women must be over 18 years old, speak and read English, and have been experiencing pudendal pain or chronic pelvic pain for at least three months. They should also have a pain score of at least 4 out of 10 and be interested in receiving a pudendal nerve block. However, certain factors like being pregnant, having had a recent pudendal nerve block or pelvic surgery, or having specific infections or medical conditions may prevent someone from joining. Participants can expect to receive either of the two nerve block treatments and will be monitored for pain relief outcomes, contributing valuable information to help improve care for those with similar conditions.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • women \>18 years
  • English speaking/reading
  • Diagnosis of pudendal neuralgia OR chronic pelvic pain with pain in the distribution of the pudendal nerve for 3 months or longer
  • Minimum pain/bother score of 4/10
  • Desire for pudendal nerve block
  • Exclusion Criteria:
  • Contraindication to pudendal nerve block (examples: skin or vaginal infection, bupivacaine allergy, uncorrected coagulopathy)
  • Pregnant or intending to become pregnant during the study
  • Pudendal nerve block from any route within the last 3 months
  • Major pelvic surgery within the last 3 months (examples: hysterectomy, prolapse repair, midurethral sling)
  • Neurologic disease affecting the perineum (examples: spinal cord injury, multiple sclerosis)

About University Of Louisville

The University of Louisville is a distinguished academic institution known for its commitment to advancing medical research and clinical innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct pioneering studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on interdisciplinary collaboration and community engagement, the University of Louisville fosters an environment conducive to groundbreaking research across various medical fields, ensuring adherence to the highest ethical standards and regulatory compliance. Through its clinical trials, the university seeks to translate scientific discoveries into tangible benefits for patients and the broader community.

Locations

Louisville, Kentucky, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported